ArchivesJohn Walker2023-02-27T20:11:47-08:00

Archives

2608, 2025

Prometheus Laboratories Announces Collaboration with Celltrion for Anser® Testing

Chrystal Johnson2025-08-25T10:53:45-07:002025-08-26|

News & Events Prometheus Laboratories [...]

2907, 2025

Prometheus Laboratories Expands Precision-Guided Dosing Tests with the Launch of PredictrPK® VDZ and UST

Chrystal Johnson2025-07-28T14:23:56-07:002025-07-29|

News & Events Prometheus Laboratories [...]

1706, 2025

PredictrPK® ADA, a Precision-Guided Dosing Test Supporting Adalimumab Treatment Optimization, Demonstrates Strong Clinical Utility in New Study

Chrystal Johnson2025-06-16T13:59:16-07:002025-06-17|

News & Events PredictrPK® ADA, [...]

405, 2025

Prometheus Laboratories Presents Novel Data on Precision-Guided Care in IBD at DDW® 2025

Chrystal Johnson2025-05-01T17:07:18-07:002025-05-04|

News & Events Prometheus Laboratories [...]

2904, 2025

Prometheus Laboratories Launches First Pre-Therapy Test to Predict Likelihood of Biologic Response

Chrystal Johnson2025-04-29T08:23:51-07:002025-04-29|

News & Events Prometheus Laboratories [...]

104, 2025

Prometheus Laboratories Launches New Anser® Test for Risankizumab

Chrystal Johnson2025-03-31T11:05:14-07:002025-04-01|

News & Events Prometheus [...]